Ekso Bionics Holdings, Richmond, California, announced that Thomas Looby has been appointed president and interim CEO, effective immediately. It also announced the resignation of company cofounder Nathan Harding from the position of CEO and from the board of directors.
Looby had been the company’s president and chief commercialization officer, where he was responsible for overseeing the operations of Ekso Bionics’ medical business. He joined the company in April 2014 as the chief marketing officer, leading the development and execution of its global rehabilitation marketing strategy.
“Tom is a healthcare industry veteran with an excellent track record for growing organizations and successfully building commercial platforms to create value for shareholders,” said Steven Sherman, chairman of the board of directors. “On behalf of the entire board of directors, I sincerely thank Nate for his many years of dedication and contributions to Ekso Bionics.”
“After almost 13 years of working to build an exoskeleton industry…, I feel confident we have assembled a fantastic team; as the company transitions into a commercial entity, I am ready to pursue new ventures,” said Harding. “Success in high-tech healthcare markets starts with great technology and then also depends on strategic market development and execution,” said Looby. “I am thrilled to build off of the great technology that Nate and Russ have developed.”
